78 related articles for article (PubMed ID: 17667527)
1. Scalable expansion of potent genetically modified human langerhans cells in a closed system for clinical applications.
Yuan J; Kendle R; Ireland J; Heller G; Sadelain M; Young JW; Rivière I
J Immunother; 2007 Sep; 30(6):634-43. PubMed ID: 17667527
[TBL] [Abstract][Full Text] [Related]
2. Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responses.
Yuan J; Latouche JB; Reagan JL; Heller G; Riviere I; Sadelain M; Young JW
J Immunol; 2005 Jan; 174(2):758-66. PubMed ID: 15634896
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.
Ueno H; Tcherepanova I; Reygrobellet O; Laughner E; Ventura C; Palucka AK; Banchereau J
J Immunol Methods; 2004 Feb; 285(2):171-80. PubMed ID: 14980432
[TBL] [Abstract][Full Text] [Related]
4. Efficient transduction and long-term retroviral expression of the melanoma-associated tumor antigen tyrosinase in CD34(+) cord blood-derived dendritic cells.
Temme A; Morgenroth A; Schmitz M; Weigle B; Rohayem J; Lindemann D; Füssel M; Ehninger G; Rieber EP
Gene Ther; 2002 Nov; 9(22):1551-60. PubMed ID: 12407427
[TBL] [Abstract][Full Text] [Related]
5. Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner.
Yuan J; Latouche JB; Hodges J; Houghton AN; Heller G; Sadelain M; Riviere I; Young JW
J Immunol; 2006 Feb; 176(4):2357-65. PubMed ID: 16455993
[TBL] [Abstract][Full Text] [Related]
6. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells.
Ratzinger G; Baggers J; de Cos MA; Yuan J; Dao T; Reagan JL; Münz C; Heller G; Young JW
J Immunol; 2004 Aug; 173(4):2780-91. PubMed ID: 15294997
[TBL] [Abstract][Full Text] [Related]
7. Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity.
Tran CA; Burton L; Russom D; Wagner JR; Jensen MC; Forman SJ; DiGiusto DL
J Immunother; 2007 Sep; 30(6):644-54. PubMed ID: 17667528
[TBL] [Abstract][Full Text] [Related]
8. Efficient transduction of monocyte- and CD34+-derived Langerhans cells with lentiviral vectors in the absence of phenotypic and functional maturation.
Veron P; Boutin S; Bernard J; Danos O; Davoust J; Masurier C
J Gene Med; 2006 Aug; 8(8):951-61. PubMed ID: 16741998
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
10. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
[TBL] [Abstract][Full Text] [Related]
11. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells.
Platzer B; Richter S; Kneidinger D; Waltenberger D; Woisetschläger M; Strobl H
J Immunol; 2009 Jul; 183(1):66-74. PubMed ID: 19535631
[TBL] [Abstract][Full Text] [Related]
12. Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL.
Cao T; Ueno H; Glaser C; Fay JW; Palucka AK; Banchereau J
Eur J Immunol; 2007 Sep; 37(9):2657-67. PubMed ID: 17683111
[TBL] [Abstract][Full Text] [Related]
13. Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.
Forsberg O; Carlsson B; Tötterman TH; Essand M
Br J Haematol; 2008 Apr; 141(2):188-99. PubMed ID: 18307565
[TBL] [Abstract][Full Text] [Related]
14. Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy.
Besser MJ; Schallmach E; Oved K; Treves AJ; Markel G; Reiter Y; Schachter J
Cytotherapy; 2009; 11(2):206-17. PubMed ID: 19148842
[TBL] [Abstract][Full Text] [Related]
15. The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells.
Fujisawa Y; Nabekura T; Nakao T; Nakamura Y; Takahashi T; Kawachi Y; Otsuka F; Onodera M
Exp Dermatol; 2009 Apr; 18(4):396-403. PubMed ID: 19054057
[TBL] [Abstract][Full Text] [Related]
16. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
[TBL] [Abstract][Full Text] [Related]
17. Freshly isolated Langerhans cells negatively regulate naïve T cell activation in response to peptide antigen through cell-to-cell contact.
Imai Y; Hayashi N; Yasuda K; Tsutsui H; Mizutani H; Nakanishi K
J Dermatol Sci; 2008 Jul; 51(1):19-29. PubMed ID: 18367382
[TBL] [Abstract][Full Text] [Related]
18. Positive selection and expansion of cytomegalovirus-specific CD4 and CD8 T cells in sealed systems: potential applications for adoptive cellular immunoreconstitution.
Li Pira G; Ivaldi F; Tripodi G; Martinengo M; Manca F
J Immunother; 2008 Oct; 31(8):762-70. PubMed ID: 18779743
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions.
Su Z; Frye C; Bae KM; Kelley V; Vieweg J
Clin Cancer Res; 2008 Oct; 14(19):6207-17. PubMed ID: 18829500
[TBL] [Abstract][Full Text] [Related]
20. Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield.
Lamers CH; van Elzakker P; van Steenbergen SC; Sleijfer S; Debets R; Gratama JW
Cytotherapy; 2008; 10(4):406-16. PubMed ID: 18574773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
